According to GlobalData’s medical device pipeline database, 19 Minimally Invasive Spinal Devices devices are in various stages of development globally. GlobalData’s report Minimal Invasive Spinal Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, eight are in active development, while the remaining 11 are in an inactive stage of development. There are five products in the early stages of development, and the remaining three are in the late stages of development.
Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws. MIS fusion surgery features shorter incisions and faster recovery time when compared to traditional or open procedures. In the segment we have covered four minimally invasive spine surgery techniques: Mini-open, Percutaneous, Tubular, Distally Expanding. In this segment, we are tracking MIS procedures performed as spinal fusion. We are not tracking MIS surgeries related to spinal non-fusion and vertebral compression fractures. Thoraco-lumbar procedures include sacral procedures. Also, all screw fixations including pedicle and facet are tracked in this segment. Facet screw fixation, vertebral body replacements and spinous process fixation are not tracked in this model. Hence, the sum of minimally invasive spinal procedures utilizing devices is not 100%.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Minimally Invasive Spinal Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Minimally Invasive Spinal Devices devices. Overall, most of these Minimally Invasive Spinal Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Minimally Invasive Spinal Devices include SeaSpine, Implanet, Integra LifeSciences, MicroPort Scientific, OrthoPediatrics, OxSonics, Safe, Stryker, SurGenTec and Chaim Sheba Medical Center.
For a complete picture of the developmental pipeline for Minimally Invasive Spinal Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
